These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34554688)

  • 1. Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin.
    Viel E; Eerdekens M; Kandaswamy P
    Pain Physician; 2021 Sep; 24(6):453-463. PubMed ID: 34554688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
    Haanpää M; Cruccu G; Nurmikko TJ; McBride WT; Docu Axelarad A; Bosilkov A; Chambers C; Ernault E; Abdulahad AK
    Eur J Pain; 2016 Feb; 20(2):316-28. PubMed ID: 26581442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice.
    Saldaña MT; Pérez C; Navarro A; Masramón X; Rejas J
    Clin Drug Investig; 2012 Jun; 32(6):401-12. PubMed ID: 22480279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany.
    Kern KU; Quandel T; Theis S; Schubert T
    Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
    Perrot S; Lantéri-Minet M
    Eur J Pain; 2019 Jul; 23(6):1117-1128. PubMed ID: 30793414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
    Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
    Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
    Blair HA
    Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
    Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain.
    Cruccu G; Nurmikko TJ; Ernault E; Riaz FK; McBride WT; Haanpää M
    Eur J Pain; 2018 Apr; 22(4):700-706. PubMed ID: 29194851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Neuropathic Pain Following Breast Cancer: Effectiveness and Tolerability of High-Concentration Capsaicin Patch.
    Dupoiron D; Jubier-Hamon S; Seegers V; Bienfait F; Pluchon YM; Lebrec N; Jaoul V; Delorme T
    J Pain Res; 2022; 15():241-255. PubMed ID: 35136354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland.
    Mankowski C; Patel S; Trueman D; Bentley A; Poole C
    PLoS One; 2016; 11(3):e0150973. PubMed ID: 26983018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
    Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
    Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.